Matches in Wikidata for { <http://www.wikidata.org/entity/Q99411169> ?p ?o ?g. }
- Q99411169 description "2020 nî lūn-bûn" @default.
- Q99411169 description "2020 թվականի սեպտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q99411169 description "2020年の論文" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年学术文章" @default.
- Q99411169 description "2020年學術文章" @default.
- Q99411169 description "2020年學術文章" @default.
- Q99411169 description "2020年學術文章" @default.
- Q99411169 description "2020年學術文章" @default.
- Q99411169 description "2020年學術文章" @default.
- Q99411169 description "2020년 논문" @default.
- Q99411169 description "article científic" @default.
- Q99411169 description "article scientific" @default.
- Q99411169 description "article scientifique" @default.
- Q99411169 description "articol științific" @default.
- Q99411169 description "articolo scientifico" @default.
- Q99411169 description "artigo científico" @default.
- Q99411169 description "artigo científico" @default.
- Q99411169 description "artigo científico" @default.
- Q99411169 description "artikel ilmiah" @default.
- Q99411169 description "artikull shkencor" @default.
- Q99411169 description "artikulong pang-agham" @default.
- Q99411169 description "artykuł naukowy" @default.
- Q99411169 description "artículo científico publicado en 2020" @default.
- Q99411169 description "artículu científicu" @default.
- Q99411169 description "bilimsel makale" @default.
- Q99411169 description "bài báo khoa học" @default.
- Q99411169 description "naučni članak" @default.
- Q99411169 description "scienca artikolo" @default.
- Q99411169 description "scientific article published on 10 September 2020" @default.
- Q99411169 description "scientific article published on 10 September 2020" @default.
- Q99411169 description "scientific article published on 10 September 2020" @default.
- Q99411169 description "teaduslik artikkel" @default.
- Q99411169 description "tieteellinen artikkeli" @default.
- Q99411169 description "tudományos cikk" @default.
- Q99411169 description "vedecký článok" @default.
- Q99411169 description "vetenskaplig artikel" @default.
- Q99411169 description "videnskabelig artikel udgivet 10. september 2020" @default.
- Q99411169 description "vitenskapelig artikkel" @default.
- Q99411169 description "vitskapeleg artikkel" @default.
- Q99411169 description "vědecký článek" @default.
- Q99411169 description "wetenschappelijk artikel" @default.
- Q99411169 description "wissenschaftlicher Artikel" @default.
- Q99411169 description "επιστημονικό άρθρο" @default.
- Q99411169 description "мақолаи илмӣ" @default.
- Q99411169 description "наукова стаття, опублікована у вересні 2020" @default.
- Q99411169 description "научна статия" @default.
- Q99411169 description "научная статья" @default.
- Q99411169 description "научни чланак" @default.
- Q99411169 description "научни чланак" @default.
- Q99411169 description "מאמר מדעי" @default.
- Q99411169 description "مقالة علمية نشرت في 10 سبتمبر 2020" @default.
- Q99411169 description "১০ সেপ্টেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q99411169 description "บทความทางวิทยาศาสตร์" @default.
- Q99411169 description "სამეცნიერო სტატია" @default.
- Q99411169 name "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 name "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 type Item @default.
- Q99411169 label "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 label "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 prefLabel "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 prefLabel "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 P1433 Q99411169-F731A2ED-CACD-4666-A4E2-77FA02AAD33F @default.
- Q99411169 P1476 Q99411169-64FBB0F0-9DE9-4429-93D8-EB127ABD1668 @default.
- Q99411169 P2093 Q99411169-30CC0981-F5E8-4BC8-B9E8-CDFBE96B2D00 @default.
- Q99411169 P2093 Q99411169-4DEB3446-4E4E-422C-B16F-BD2F9887053E @default.
- Q99411169 P2093 Q99411169-4E6DD8A3-D72E-4AF3-8EC4-05F06366B798 @default.
- Q99411169 P2093 Q99411169-5ECA3D4D-E9B8-46CA-8764-83C35A141F82 @default.
- Q99411169 P2093 Q99411169-65E20218-46F3-4ECF-9262-3A851028BC61 @default.
- Q99411169 P2093 Q99411169-793DDA26-17DD-43D8-949D-71FB56A3E7A4 @default.
- Q99411169 P2093 Q99411169-C68B24C6-230B-4842-98C9-177B71B00E40 @default.
- Q99411169 P2093 Q99411169-CA33D861-FA52-47E3-8C93-1E17A532AC59 @default.
- Q99411169 P2093 Q99411169-E12CFEF0-DFCA-49B2-B3F1-129040A00611 @default.
- Q99411169 P2093 Q99411169-E75B7987-A9A8-4074-A5A9-05D0F9009064 @default.
- Q99411169 P2093 Q99411169-EB3AAE6D-AEA0-458D-83C1-CDCACC000460 @default.
- Q99411169 P2093 Q99411169-F1DAB536-D20D-4BBA-8716-6EE6C98E5966 @default.
- Q99411169 P2093 Q99411169-F53491C9-0473-4575-9745-81D565B6F15E @default.
- Q99411169 P31 Q99411169-595D69A3-7B37-40B1-AEA9-0AD9A3BAF6CB @default.
- Q99411169 P356 Q99411169-DCF09FBF-7301-45B9-9977-3631A8854C8E @default.
- Q99411169 P577 Q99411169-429B9EDD-B38D-4C9A-AD20-31C5FAEE4EA2 @default.
- Q99411169 P698 Q99411169-4C29AD7D-8C6E-4DE1-AF3E-0DD630D243C1 @default.
- Q99411169 P921 Q99411169-2867ED55-CE3E-4E56-9BF5-71772F41C06E @default.
- Q99411169 P356 CM9.0000000000001099 @default.
- Q99411169 P698 32925287 @default.
- Q99411169 P1433 Q5100534 @default.
- Q99411169 P1476 "Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5" @default.
- Q99411169 P2093 "Brian Porter" @default.
- Q99411169 P2093 "Fei Sun" @default.
- Q99411169 P2093 "Feng Huang" @default.
- Q99411169 P2093 "Hao-Min Qiu" @default.
- Q99411169 P2093 "Ladislav Šenolt" @default.
- Q99411169 P2093 "Li-Jun Wu" @default.
- Q99411169 P2093 "Ling-Li Dong" @default.
- Q99411169 P2093 "Raj Sengupta" @default.
- Q99411169 P2093 "Sibylle Haemmerle" @default.
- Q99411169 P2093 "Tae-Hwan Kim" @default.